Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Post-transplantation cyclophosphamide-based after HLA-matched versus haploidentical donor transplants in patients with Hodgkin lymphoma: a comparative study of the LWP EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Dr. Juan Montoro

Frequency and Impact of Pre-Transplant Somatic Co-Occurring Mutations on Clinical Outcomes of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: On Behalf of the EBMT Acute Leukemia Working Party

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of treatment

Principal investigator

Long term outcomes and relative mortality in survivors of allogeneic hematopoietic cell transplantation in acute myeloid leukemia: an analysis from the ALWP of the EBMT

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of treatment

Principal investigator

Outcome of haploidentical transplant in chronic granulomatous disease

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Benedicte Neven

Prospective study on the incidence and outcome of HHV-6 encephalitis in patients who undergo allogeneic haploidentical HSCT

Non-interventional Prospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Katia Perruccio

Allo-HCT in CLL after multiple pathway inhibitors.

Retrospective Studies

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Michel van Gelder/Olivier Tournilhac

Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres.

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Non-Tuberculous Mycobacterial infections post-hematopoietic stem cell transplantation

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Daratumumab for PRCA after alloSCT

Retrospective Studies

Complications: non-infectious

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Outcomes of PT-CY in elderly AML/MDS

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Maria Queralt Salas

Immune Checkpoint Inhibitors for solid tumors after allogeneic stem cell transplantation

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Pre-transplantation diabetes and obesity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation

Retrospective Studies

Complications: GvHD

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Lars Klingen Gjaerde